Adial pharmaceuticals ceo to participate in a fireside chat at the 2022 virtual growth conference presented by maxim group llc and hosted by m-vest on march 28th

Charlottesville, va., march 22, 2022 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil; adilw) (“adial” or the “company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that william stilley, adial's chief executive officer will participate in a fireside chat at the 2022 virtual growth conference, presented by maxim group llc and hosted by m-vest, being held virtually on march 28th - 30th from 9:00 a.m. - 5:00 p.m. edt. those who wish to attend the conference must first sign up to become an m-vest member.
ADIL Ratings Summary
ADIL Quant Ranking